Suppr超能文献

2022 - 2023年秋冬美国新冠病毒病与流感相关结局比较:一项横断面回顾性研究

Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall-Winter 2022-2023: A Cross-Sectional Retrospective Study.

作者信息

Kopel Hagit, Bogdanov Alina, Winer-Jones Jessamine P, Adams Christopher, Winer Isabelle H, Bonafede Machaon, Nguyen Van Hung, Mansi James A

机构信息

Moderna, Inc., Cambridge, MA 02139, USA.

Veradigm, Chicago, IL 60654, USA.

出版信息

Diseases. 2024 Jan 3;12(1):16. doi: 10.3390/diseases12010016.

Abstract

Influenza and COVID-19 contribute significantly to the infectious disease burden during the respiratory season, but their relative burden remains unknown. This study characterizes the frequency and severity of medically attended COVID-19 and influenza during the peak of the 2022-2023 influenza season in the pediatric, adult, and older adult populations and characterizes the prevalence of underlying conditions among patients hospitalized with COVID-19. This cross-sectional analysis included individuals in the Veradigm EHR Database linked to Komodo claims data with a medical encounter between 1 October 2022 and 31 March 2023 (study period). Patients with medical encounters were identified with a diagnosis of COVID-19 or influenza during the study period and stratified based on the highest level of care received with that diagnosis. Among 23,526,196 individuals, there were more COVID-19-related medical encounters than influenza-related encounters, overall and by outcome. Hospitalizations with COVID-19 were more common than hospitalizations with influenza overall (incidence ratio = 4.6) and in all age groups. Nearly all adults hospitalized with COVID-19 had at least one underlying medical condition, but 37.1% of 0-5-year-olds and 25.0% of 6-17-year-olds had no underlying medical conditions. COVID-19 was associated greater burden than influenza during the peak of the 2022-2023 influenza season.

摘要

流感和新冠病毒对呼吸道疾病流行季节的传染病负担有重大影响,但其相对负担仍不明确。本研究描述了2022 - 2023年流感季节高峰期儿科、成人和老年人群中因新冠病毒和流感就医的频率和严重程度,并描述了新冠病毒住院患者潜在疾病的患病率。这项横断面分析纳入了Veradigm电子健康记录数据库中与科莫多理赔数据相关联的个体,这些个体在2022年10月1日至2023年3月31日(研究期间)有过医疗接触。研究期间确定有新冠病毒或流感诊断的有医疗接触的患者,并根据该诊断所接受的最高护理级别进行分层。在23,526,196名个体中,总体及按结果来看,与新冠病毒相关的医疗接触比与流感相关的接触更多。总体而言(发病率比 = 4.6)以及在所有年龄组中,新冠病毒住院比流感住院更常见。几乎所有因新冠病毒住院的成年人都至少有一种基础疾病,但0至5岁儿童中有37.1%、6至17岁儿童中有25.0%没有基础疾病。在2022 - 2023年流感季节高峰期,新冠病毒造成的负担比流感更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec78/10814040/ce13654eee8f/diseases-12-00016-g001a.jpg

相似文献

2
Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.
J Med Econ. 2024 Jan-Dec;27(1):324-336. doi: 10.1080/13696998.2024.2314429. Epub 2024 Feb 22.
5
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
7
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
JAMA Netw Open. 2024 Apr 1;7(4):e244954. doi: 10.1001/jamanetworkopen.2024.4954.
9
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.

引用本文的文献

本文引用的文献

1
Postacute sequelae of COVID-19 at 2 years.
Nat Med. 2023 Sep;29(9):2347-2357. doi: 10.1038/s41591-023-02521-2. Epub 2023 Aug 21.
2
Incidence of New-Onset Hypertension Post-COVID-19: Comparison With Influenza.
Hypertension. 2023 Oct;80(10):2135-2148. doi: 10.1161/HYPERTENSIONAHA.123.21174. Epub 2023 Aug 21.
3
Relative Effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines and Homologous Boosting in Preventing COVID-19 in Adults in the US.
Open Forum Infect Dis. 2023 May 25;10(7):ofad288. doi: 10.1093/ofid/ofad288. eCollection 2023 Jul.
5
COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023.
MMWR Morb Mortal Wkly Rep. 2023 May 12;72(19):523-528. doi: 10.15585/mmwr.mm7219e1.
6
Long COVID Incidence in a Large US Ambulatory Electronic Health Record System.
Am J Epidemiol. 2023 Aug 4;192(8):1350-1357. doi: 10.1093/aje/kwad095.
7
8
The evolution of SARS-CoV-2.
Nat Rev Microbiol. 2023 Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2. Epub 2023 Apr 5.
9
Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis.
JAMA Intern Med. 2023 Jun 1;183(6):566-580. doi: 10.1001/jamainternmed.2023.0750.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验